ABSTRACT: Six clinica l isolates of Enterococcus jaecium highly resistant to pen icillin are reported. These strains did not produce beta-lactamase and no plas mid DNA cou ld be detected . It is postulated tha t the mechanism of resistance is one or more chromosoma lly E NTEROCOCCI ARE RESPONSIBLE FOR VARIOUS INFECtions such as bacteremias, endoca rditis and urinary tract infections , and participate in polymicnbial intra-abdomina l a nd pelvic infections. Enterococci in general h ave higher minimal inhibitory concentrations (M!Cgo) to penicillin than streptococci. Of the enterococci, Enierococcusjaecium, the second most common enterococcallaboratory isolate, has a higher M!Cgo than E jaecalis, the most common isolate (l) . To achieve bactericidal effects the recommended treatment of serious enterococcal infections has consisted of either penicillin, ampicillin or vancomycin in combination with an amin oglycoside.
a mpicillin (5) . The mechanism of enterococcal penicillin resistance has been associated both with the presence (5,6) and absence (3, 4) of betalactamase production by the organism. Six clinical isolates of Ejaeciumhighly resistant to penicillin that were not beta-lactamase producers a re reported . The purpose of this report is to make the clinician aware of such microorganisms which may present problems in management. All were collected from patients seen in the authors' hospital between February and July 1988.
PATIENTS AND METHODS
For each clinical isolate the patient's chart was reviewed. In the authors' laboratory enterococcus was identified on the basis of Gram stain, negative catalase, tolerance to bile esculin, growth in 6.5% sodium chloride broth, hydrolysis of L-pyrrolidonyl-beta-naphthylamide and vancomycin susceptibility. Using 27 different biochemical tests. identification and speciation were confirmed by the National Streptococcus Reference Centre of the Laboratory Centre for Disease Control in Ottawa, Ontario. Disk diffusion susceptibilities were performed on all isolates by standard methods on Mueller-Hinton agar (BBL Microbiology System, Cockeysville, Maryland). Ampicillin 10 ~g disks Beta-lactamase production was assessed by the chromogenic cephalosporin test (nitrocefin) and the acidometric test (both from Oxoid Ltd, Basingstoke, United Kingdom). The presence of plasmid DNA was examined by isolation of nucleic acids from overnight cultures (5 mL) grown in trypticase soy broth containing 50 ~g/mL of ampicillin. The rapid small scale boiling method of Holmes and Quigley (9) was used to extract nucleic acid. Samples were analyzed on a l% agarose gel.
RESULTS
Clinical evaluation revealed that these enterococci were pathogens in all six patientshospital-acquired in four of six and associated with foreign devices in three (Table l) . During therapy the two PortaCaths were left in place; the 74 ventricular drain was removed but not cultured; and the arterial line tip grew resistant E jaecium. Four patients were immunocompromised and four of six had received one or multiple courses of antibiotics for between seven and 42 days (mean 25) prior to the isolation of the enterococcus. Eradication of E jaecium could be documented in four patients during vancomycin therapy: one was cured; three were cured bacteriologically but died during admission long after the isolation of enterococcus, from complications of their underlying diseases. Patient 5 was treated with vancomycin only three days before she expired and no further specimens were sent for culture. Of note is the fact that she also had Pneumocystis carinii, cytomegalovirus and candida isolated from transbronchial biopsy, and these pathogens contributed to her pulmonary deterioration.
All enterococci were identified as E jaecium. There was no zone of inhibition around the ampicillin disks for any of the clinical isolates ( 
DISCUSSION
Enterococci are intrinsically resistant to many antibiotics such as clindamycin, penicillinaseresistant penicillin and the cephalosporins (12) . Acquired plasmid-mediated resistance to erythromycin, chloramphenicol and tetracycline is common, as is high level resistance to aminoglycosides (1,2,6 ).
Several years ago beta-lactamase-producing strains were described (5) . Recently, Leclercq and co-workers (3) reported a vancomycin-resistant strain that was also ampicillin-resistant and did not produce beta-lactamase. The present six penicillin-resistant enterococcu s strains did not produce beta-lactamase and had no plasmid DNA, and it is therefore postulated that the mechanism of penicillin resistance of these strains may be an alteration of penicillin-binding proteins, previously described by Williamson (1 2).
An outbreak of neonatal sepsis due to Ejaecium was previously reported (13) . Sim ilar to the present patients. the seven cases reported were severely ill, had invasive devices and had received prior antibiotherapy. Although isolates were a ll resistant to ampicillin (MICs greater than or equ al to 25 ~g/mL) and no plasmids were seen, there is no mention regarding presence of beta-lactamase nor regarding susceptibility to vancomycin. The present cases do not represent an outbreak: six cases occurred over a six month period; two were community-acquired and those that were nosocomial were admitted to different units and taken care of by d ifferent nursing and medical personnel.
Bush a[ld coll eagues (14) have reported isolation from clin ical specimens of Ejaecium resistant to penicillin and not producing beta-lactamase. They d id not, however. report on the presence of plasmid DNA in their strains. nor was a deta il ed description of the clinical status of the patients given .
Sapico a nd coll eagues (15) reported 16 pa ti ents from whom beta-lactamase n egative. ampicillinresista nt enterococci were isolated. Similar to the present cases, their strains were tolerant to vancomycin and in the majority of cases isolated after antibiotherapy and nosocomially acquired. Some of the organisms in that report could h ave been colonizers rath er than pathogens: 11 of 16 were in mixed culture: five were isolated from skin lesions : and another five grew from the urine of asymptomatic patients. Furthermore, therapy directed at the resistant organisms was initiated in only seven patients with no m e ntion of outcome. Aga in. the presence of plasmid DNA was not evaluated.
At the authors· institution, beta-lactamase negative penicillin-resistant enterococci had not been isolated prior to 1988. and th e rate of isolalion of these strains decreased in the following year. This phenomenon could not b e linked to any particular change in the use of a ntibiotics in th e a uthors· hospita l. The manage ment of these patients gives some cause for concern with respect to th e choice of a ntibiotics. Nthough four of the fiv e pa tients treated with vancomycin died, these should not be considered therapeutic fa ilures since a review of these cases revealed the cause of death to be unrelated to the enterococcal infection .
Further. vancomycin therapy did lead to eradication of the organism in at least four of five cases . This observation h ighlights the need for continu ed routine penicillin or a mpicillin sens itivity testing in clinical isolates of enterococci especially from body fluid and blood cultures of hospita lized patients using NCCLS standards. From Table 1 it can been seen that all six of the present patients either ha d a foreign d evice present, received prior antibiotics or were immunocompromised. Four of six were considered as nosocomial infections s ince th ey were acquired a fte r 72 h of hospitalization . Institutions that note the presen ce of s u ch strains may consider vancomycin for initial ma nagement of seriously ill patients pending susceptibility tests. Furthermore. in view of the recent reports of vancomycinresistant enterococci. continued screening for vancomycin susceptibility seems to be warranted. A conclusion regarding th e role of addition of an a minoglycoside to vancomycin in the treatment of these cases cannot be made on the basis of the pa ti ents reported here.
